The National Institutes of Health (NIH) announced that it will soon embark on a major research effort to find scientific alternatives to human fetal tissue, as a result of the recent directive from the US Department of Health and Human Services for internal NIH scientists to stop procuring human fetal tissue for use in research. Warner Greene tells TIME why the administration's decision has been devastating for his research program.
The Washington Post
The Washington Post reports that the US administration has shut down at least one government-run study that uses fetal tissue implanted into mice even before federal health officials reach a decision on whether to continue such research. Warner Greene, who was a collaborator on that study, describes how this could impact his research for an HIV cure.
Researchers at the National Institutes of Health (NIH) have been ordered not to acquire new fetal tissue for their research since September, as the US administration began an audit of using the tissue funded by the NIH and other agencies. STAT News asks Warner Greene how this will affect his research to examine how HIV reservoirs get established.
The US administration has ordered scientists employed by the National Institutes of Health to stop acquiring new human fetal tissue for experiments, reports ScienceInsider. Warner Greene explains how this has impacted his HIV research and the scientific field.
This article by WIRED magazine describes work at Gladstone by Bruce Conklin, Jennifer Doudna, and Todd McDevitt to establish the epicenter of a whole new field of medicine: genome surgery. Their efforts are perhaps the most concentrated push in a national effort to create the tools and rules necessary for doctors to widely adopt genome editing as part of standard care for the 25 million Americans estimated to be living with one of 6,000 diseases caused by a glitch in their DNA.
Good Morning America
Jennifer Doudna expresses concern that a scientist claiming to have created the first gene-edited babies broke from the international consensus within the scientific community calling for an open and transparent approach for any clinical use of human embryo editing.
San Francisco Business Times
In its weekly health care digest, the San Francisco Business Times highlights the new laboratory set up at Gladstone by Seth Shipman, whose work combines synthetic biology, genetics and neuroscience.
NIH Director's Blog
In his blog, NIH Director Francis Collins describes work by Bruce Conklin. He and his colleagues at UC Berkeley developed a new model that can mimic different degrees of stress that the heart may experience, for example, during exercise or in a person with high blood pressure.
Medium / UCSF Magazine
This post on Medium describes efforts at Gladstone by Jennifer Doudna and Bruce Conklin to bring CRISPR genome editing tools into the clinic to cure disease using an approach coined “genome surgery.”
The Washington Post
Many scientists are urging a halt to clinical trials that were based partly on falsified data published by a prominent researcher from Harvard Medical School. Deepak Srivastava comments to The Washington Post that it’s time to pause and evaluate such trials.